[1]刘 薇,吴开奇.乙型肝炎表面抗原阳性对妊娠期肝内胆汁淤积症及围产期母婴结局的影响[J].医学信息,2023,36(22):73-77.[doi:10.3969/j.issn.1006-1959.2023.22.015]
　LIU Wei,WU Kai-qi.Effect of HBsAg-positive on Intrahepatic Cholestasis of Pregnancy and Perinatal Maternal and Infant Outcomes[J].Journal of Medical Information,2023,36(22):73-77.[doi:10.3969/j.issn.1006-1959.2023.22.015]
点击复制

乙型肝炎表面抗原阳性对妊娠期肝内胆汁淤积症及围产期母婴结局的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年22期
页码:
73-77
栏目:
论著
出版日期:
2023-11-15

文章信息/Info

Title:
Effect of HBsAg-positive on Intrahepatic Cholestasis of Pregnancy and Perinatal Maternal and Infant Outcomes
文章编号:
1006-1959（2023）22-0073-05
作者:
刘 薇; 吴开奇
（浙江大学医学院附属妇产科医院检验科，浙江 杭州 310006）
Author(s):
LIU Wei; WU Kai-qi
(Department of Clinical Laboratory,the Affiliated Obstetrics and Gynecology Hospital,Zhejiang University School of Medicine,Hangzhou 310006,Zhejiang,China)
关键词:
妊娠期肝内胆汁淤积症; 乙型肝炎表面抗原; 母婴结局
Keywords:
Intrahepatic cholestasis of pregnancy; Hepatitis B surface antigen; Maternal and infant outcomes
分类号:
R512.6
DOI:
10.3969/j.issn.1006-1959.2023.22.015
文献标志码:
A
摘要:
目的 探讨乙型肝炎表面抗原阳性对妊娠期肝内胆汁淤积症（ICP）及围产期母婴结局的影响。方法 选择2018年1月-12月于我院住院分娩的1173例乙型肝炎表面抗原携带孕妇作为HBsAg阳性组，另选取同期19 838例无乙型肝炎表面抗原携带孕妇作为HBsAg阴性组，比较两组年龄、孕前体重指数、剖腹产史、经产妇、试管婴儿、流产史、双胎、ALT＞40 U/L及ICP发生率，Logistic回归分析HBsAg阳性与ICP发生风险的关系，并进一步比较ICP合并HBsAg阳性孕妇和单纯ICP孕妇围产期母婴结局。结果 HBsAg阳性组年龄、经产妇、试管婴儿、流产史及双胎比例和ICP发生率均高于HBsAg阴性组，差异有统计学意义（P＜0.05）；单因素和多因素Logistic回归分析显示，HBsAg阳性会增加ICP的发生风险，并且双胎、试管婴儿也是ICP发生的独立危险因素；ICP合并HBsAg阳性孕妇剖腹产、早产发生率高于单纯ICP孕妇，差异有统计学意义（P＜0.05）。结论 妊娠期HBsAg阳性可增加ICP的发生风险，并且会增加ICP孕妇早产和剖宫产的发生率。
Abstract:
Objective To investigate the effect of HBsAg-positive on intrahepatic cholestasis of pregnancy (ICP) and perinatal maternal and infant outcomes.Methods A total of 1173 pregnant women with hepatitis B surface antigen who were hospitalized in our hospital from January to December 2018 were selected as the HBsAg-positive group, and 19 838 pregnant women without hepatitis B surface antigen were selected as the HBsAg-negative group. The age, pre-pregnancy body mass index, history of caesarean section, multipara, test-tube baby, abortion history, twins, ALT>40 U/L and the incidence of ICP were compared between the two groups. Logistic regression was used to analyze the relationship between HBsAg positive and the risk of ICP. The perinatal maternal and infant outcomes of ICP combined with HBsAg positive pregnant women and simple ICP pregnant women were further compared.Results The age, multipara, IVF, abortion history, proportion of twins and incidence of ICP in HBsAg-positive group were higher than those in HBsAg-negative group, and the differences were statistically significant (P<0.05). Univariate and multivariate logistic regression analysis showed that HBsAg positive increased the risk of ICP, and twins and IVF were also independent risk factors for ICP. The incidence of cesarean section and premature delivery in ICP combined with HBsAg positive pregnant women was higher than that in ICP pregnant women, and the difference was statistically significant (P<0.05).Conclusion HBsAg-positive during pregnancy can increase the risk of ICP, and will increase the incidence of preterm birth and cesarean section in ICP pregnant women.

参考文献/References:

[1]Liu J,Wang X,Wang Q,et al.Hepatitis B virus infection among 90 million pregnant women in 2853 Chinese counties, 2015-2020: a national observational study[J].Lancet Reg Health West Pac,2021,16:100267.[2]Xia GL,Liu CB,Cao HL,et al.Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992[J].International Hepatology Communications,1996,5(1):62-73.[3]Zhou M,Wang H,Zeng X,et al.Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2019,394(10204):1145-1158.[4]Zhou Q,Li X,Wang Q,et al.Hepatitis B Virus Infection in Preconception Period Among Women of Reproductive Age in Rural China - A Nationwide Study[J].Paediatr Perinat Epidemiol,2017.[5]Smith DD,Rood KM.Intrahepatic Cholestasis of Pregnancy[J].Clin Obstet Gynecol,2020,63(1):134-151.[6]Shan D,Dong R,Hu Y.Current understanding of autophagy in intrahepatic cholestasis of pregnancy[J].Placenta,2021,115:53-59.[7]Wu K,Yin B,Li S,et al.Prevalence, risk factors and adverse perinatal outcomes for Chinese women with intrahepatic cholestasis of pregnancy:a large cross-sectional retrospective study[J].Ann Med,2022,54(1):2966-2974.[8]Luo M,Tang M,Jiang F,et al.Intrahepatic Cholestasis of Pregnancy and Associated Adverse Maternal and Fetal Outcomes: A Retrospective Case-Control Study[J].Gastroenterol Res Pract,2021,2021:6641023.[9]贺晶,杨慧霞,段涛,等.妊娠期肝内胆汁淤积症诊疗指南(2015)[J].临床肝胆病杂志,2015,31(10):1575-1578.[10]李静,许晓英,裴建赢,等.孕妇HBV携带状态与妊娠结局的研究[J].中国妇幼保健,2019,34(5):998-1001.[11]Wu K,Wang H,Li S,et al.Maternal hepatitis B infection status and adverse pregnancy outcomes: a retrospective cohort analysis[J].Arch Gynecol Obstet,2020,302(3):595-602.[12]Palmer KR,Xiaohua L,Mol BW.Management of intrahepatic cholestasis in pregnancy[J].Lancet,2019,393(10174):853-854.[13]Cui AM,Cheng XY,Shao JG,et al.Maternal hepatitis B virus carrier status and pregnancy outcomes: a prospective cohort study[J].BMC Pregnancy Childbirth,2020,16:87.[14]Cai Q,Liu H,Han W,et al.Maternal HBsAg carriers and adverse pregnancy outcomes: A hospital-based prospective cohort analysis[J].J Viral Hepat,2019,26(8):1011-1018.[15]Tan J,Liu X,Mao X,et al.HBsAg positivity during pregnancy and adverse maternal outcomes: a retrospective cohort analysis[J].J Viral Hepat,2016,23(10):812-819.[16]Cui AM,Cheng XY,Shao JG,et al.Maternal hepatitis B virus carrier status and pregnancy outcomes: a prospective cohort study[J].BMC Pregnancy Childbirth,2016,16:87.[17]Q Bartlett A,Vesco KK,Purnell JQ,et al.Pregnancy and weaning regulate human maternal liver size and function[J].Proc Natl Acad Sci U S A,2021,118(48):e2107269118.[18]李硕,李志国,叶永安.HBV感染与胆汁酸的关系[J]. 临床肝胆病杂志,2019,35(11):2561-2564.[19]高翔,张华,庞秋梅,等.乙型肝炎病毒感染对妊娠期肝内胆汁淤积症患者母婴免疫系统及妊娠结局的影响[J].中国医药导报,2015(21):59-62.[20]张丽娟.乙型肝炎病毒感染对妊娠期肝内胆汁淤积症患者围产期母婴状况的影响[J].实用临床医药杂志,2016,20(11):80-82.[21]Cui D,Zhong Y,Zhang L,et al.Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis[J].J Obstet Gynaecol Res,2017,43(9):1411-1420.

相似文献/References:

[1]周宏芳.熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者的临床疗效及对母婴结局的影响[J].医学信息,2022,35(16):94.[doi:10.3969/j.issn.1006-1959.2022.16.022]
　ZHOU Hong-fang.Clinical Effect of Ursodeoxycholic Acid in Treatment of Patients with Intrahepatic Cholestasis of Pregnancy and its Influence on Maternal and Infant Outcomes[J].Journal of Medical Information,2022,35(22):94.[doi:10.3969/j.issn.1006-1959.2022.16.022]
[2]王国芳.丁二磺酸腺苷蛋氨酸联合多烯磷脂酰胆碱治疗妊娠期肝内胆汁淤积症的临床疗效及对母婴结局的影响[J].医学信息,2023,36(18):144.[doi:10.3969/j.issn.1006-1959.2023.18.028]
　WANG Guo-fang.Clinical Effect of Ademetionine 1,4-Butanedisulfonate Combined with Polyene Phosphatidylcholine in the Treatment of Intrahepatic Cholestasis of Pregnancy and its Effect on Maternal and Infant Outcomes[J].Journal of Medical Information,2023,36(22):144.[doi:10.3969/j.issn.1006-1959.2023.18.028]

更新日期/Last Update: 1900-01-01